JP2023527563A5 - - Google Patents
Info
- Publication number
- JP2023527563A5 JP2023527563A5 JP2022573609A JP2022573609A JP2023527563A5 JP 2023527563 A5 JP2023527563 A5 JP 2023527563A5 JP 2022573609 A JP2022573609 A JP 2022573609A JP 2022573609 A JP2022573609 A JP 2022573609A JP 2023527563 A5 JP2023527563 A5 JP 2023527563A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- antibody
- preparation
- administration
- april
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062704831P | 2020-05-29 | 2020-05-29 | |
| US62/704,831 | 2020-05-29 | ||
| PCT/US2021/035011 WO2021243298A1 (en) | 2020-05-29 | 2021-05-28 | Methods of treating iga nephropathy with an april binding antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023527563A JP2023527563A (ja) | 2023-06-29 |
| JP2023527563A5 true JP2023527563A5 (https=) | 2024-06-06 |
| JP7843248B2 JP7843248B2 (ja) | 2026-04-09 |
Family
ID=78722933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573609A Active JP7843248B2 (ja) | 2020-05-29 | 2021-05-28 | ＡＰＲＩＬ結合抗体によるＩｇＡ腎症を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210379183A1 (https=) |
| EP (1) | EP4157339A4 (https=) |
| JP (1) | JP7843248B2 (https=) |
| KR (1) | KR20230017223A (https=) |
| CN (1) | CN115996748A (https=) |
| AU (1) | AU2021279035A1 (https=) |
| BR (1) | BR112022024262A2 (https=) |
| CA (1) | CA3179812A1 (https=) |
| IL (1) | IL298370A (https=) |
| MX (1) | MX2022014995A (https=) |
| WO (1) | WO2021243298A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL2011406C2 (en) | 2013-09-06 | 2015-03-10 | Bionovion Holding B V | Method for obtaining april-binding peptides, process for producing the peptides, april-binding peptides obtainable with said method/process and use of the april-binding peptides. |
| NL2014108B1 (en) | 2015-01-09 | 2016-09-30 | Aduro Biotech Holdings Europe B V | Altered april binding antibodies. |
| US20240092921A1 (en) | 2022-04-25 | 2024-03-21 | Visterra, Inc. | Antibody molecules to april and uses thereof |
| AU2023366516A1 (en) | 2022-10-28 | 2025-05-15 | Aduro Biotech Holdings, Europe B.V. | Treatment of iga nephropathy using an endothelin receptor antagonist and an april binding antibody |
| JP2025536433A (ja) * | 2022-11-07 | 2025-11-05 | サンレノ セラピューティクス （シャンハイ） リミテッド | ＩｇＡ腎症を治療するためのエンドセリン受容体アンタゴニストとグルココルチコイドとの組み合わせ |
| WO2026050274A2 (en) * | 2024-08-27 | 2026-03-05 | Paragon Therapeutics, Inc. | April binding proteins, compositions, and methods of use thereof |
| WO2026067804A1 (zh) * | 2024-09-30 | 2026-04-02 | 信立泰(成都)生物技术有限公司 | 一种抗april抗体或其抗原结合片段及用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA74798C2 (uk) * | 1999-10-06 | 2006-02-15 | Байоджен Айдек Ма Інк. | Спосіб лікування раку у ссавця за допомогою поліпептиду, що протидіє взаємодії april з його рецепторами |
| MXPA05010555A (es) * | 2003-04-04 | 2006-03-09 | Genentech Inc | Formulaciones de proteina y anticuerpo de alta concentracion. |
| US9168286B2 (en) * | 2005-10-13 | 2015-10-27 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive disease |
| WO2007142667A2 (en) * | 2005-10-13 | 2007-12-13 | Human Genome Sciences, Inc. | Treatment of patients with autoantibody positive disease |
| CN101678106B (zh) * | 2007-03-27 | 2013-06-05 | 津莫吉尼蒂克斯公司 | 用于治疗自身免疫疾病的BLyS抑制和/或APRIL抑制与免疫抑制剂的组合 |
| CA2738243C (en) * | 2008-10-29 | 2020-09-29 | Wyeth Llc | Formulations of single domain antigen binding molecules |
| CA2754127C (en) * | 2009-03-02 | 2017-04-18 | Stichting Top Institute Pharma | Antibodies against a proliferating inducing ligand (april) |
| NZ602685A (en) * | 2010-03-01 | 2014-10-31 | Cytodyn Inc | Concentrated protein formulations and uses thereof |
| US8613919B1 (en) * | 2012-08-31 | 2013-12-24 | Bayer Healthcare, Llc | High concentration antibody and protein formulations |
| NL2014108B1 (en) * | 2015-01-09 | 2016-09-30 | Aduro Biotech Holdings Europe B V | Altered april binding antibodies. |
| JP2018534295A (ja) * | 2015-10-28 | 2018-11-22 | アドゥロ バイオテック，インク． | 「インターフェロン遺伝子刺激因子」依存性シグナル伝達を活性化するための組成物および方法 |
| JOP20170017B1 (ar) * | 2016-01-25 | 2021-08-17 | Amgen Res Munich Gmbh | تركيب صيدلي يتضمن تركيبات جسم مضاد ثنائي الاختصاص |
| WO2018201064A1 (en) * | 2017-04-28 | 2018-11-01 | Amgen Inc. | N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides |
| JOP20190260A1 (ar) * | 2017-05-02 | 2019-10-31 | Merck Sharp & Dohme | صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها |
| CA3079946A1 (en) * | 2017-10-30 | 2019-05-09 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4r antagonist |
| CN110464842B (zh) * | 2018-05-11 | 2022-10-14 | 信达生物制药(苏州)有限公司 | 包含抗pcsk9抗体的制剂及其用途 |
-
2021
- 2021-05-28 WO PCT/US2021/035011 patent/WO2021243298A1/en not_active Ceased
- 2021-05-28 CN CN202180046732.2A patent/CN115996748A/zh active Pending
- 2021-05-28 US US17/334,590 patent/US20210379183A1/en active Pending
- 2021-05-28 KR KR1020227043773A patent/KR20230017223A/ko active Pending
- 2021-05-28 BR BR112022024262A patent/BR112022024262A2/pt unknown
- 2021-05-28 IL IL298370A patent/IL298370A/en unknown
- 2021-05-28 JP JP2022573609A patent/JP7843248B2/ja active Active
- 2021-05-28 AU AU2021279035A patent/AU2021279035A1/en active Pending
- 2021-05-28 EP EP21813022.7A patent/EP4157339A4/en active Pending
- 2021-05-28 MX MX2022014995A patent/MX2022014995A/es unknown
- 2021-05-28 CA CA3179812A patent/CA3179812A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023527563A5 (https=) | ||
| US7740842B2 (en) | Stable liquid formulations of antibodies | |
| JP2024174927A5 (https=) | ||
| US11498959B2 (en) | Anti-CGRP antibody formulation | |
| ES2253326T3 (es) | Composicion farmaceutica de acido 2-(4-isobutilfenilo)propionico. | |
| TW202146049A (zh) | 穩定的含有高濃度抗vegf抗體之蛋白質溶液調配物 | |
| JP6353577B2 (ja) | 組み合わせ組成物 | |
| JP2002544174A5 (https=) | ||
| AU2004317520B2 (en) | Stable injectable diclofenac compositions | |
| JP2022532927A5 (https=) | ||
| JP2002521329A5 (https=) | ||
| EP3681483A1 (en) | Process for lyophilized pharmaceutical formulation of a therapeutic protein | |
| WO2022135395A1 (zh) | 稳定的抗体制剂及其制备方法和应用 | |
| RU2020111574A (ru) | Высококонцентрированные, маловязкие препараты ингибирующих masp-2 антител, наборы и способы лечения субъектов, страдающих атипическим гемолитическим синдромом | |
| JP2020531523A5 (https=) | ||
| EP2604264B1 (en) | Pharmaceutical composition for treating viral diseases | |
| CN111375057A (zh) | 一种包含抗Her2单克隆抗体的药物配制剂 | |
| AU2016346703B2 (en) | Composition stably containing single-stranded nucleic acid molecule that suppresses expression of TGF-β1 gene | |
| US20220257702A1 (en) | Stable albuvirtide compositions | |
| JP2025531290A (ja) | カボテグラビルおよびリルピビリンを用いる小児患者のｈｉｖの治療 | |
| JP2022176154A5 (https=) | ||
| JP2023550043A5 (https=) | ||
| CN1870974B (zh) | 注射用加巴喷丁组合物的生产方法 | |
| JP2020172471A (ja) | ヒト化抗ヒトｃｄ２６抗体を含有する医薬組成物 | |
| AU2004281520B2 (en) | Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid |